Policy | November 11, 2025
Trump clinches historic deal as Lilly, Novo slash U.S. weight-loss drug prices
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
This predictive technology empowers people with diabetes to take preventive action before complications arise
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Offers affordable, high-quality solutions for diabetes care
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
Subscribe To Our Newsletter & Stay Updated
